Literature DB >> 15728460

Regulated folding of tyrosinase in the endoplasmic reticulum demonstrates that misfolded full-length proteins are efficient substrates for class I processing and presentation.

Marina Ostankovitch1, Valentina Robila, Victor H Engelhard.   

Abstract

Short-lived protein translation products have been proposed to be the principal substrates that enter the class I MHC processing and presentation pathway. However, the biochemical nature of these substrates is poorly defined. Whether the major processing substrates are misfolded full-length proteins, or alternatively, aberrantly initiated or truncated polypeptides still remains to be addressed. To examine this, we used melanoma in which one-third of wild-type tyrosinase molecules were correctly folded and localized beyond the Golgi, while the remainder were present in the endoplasmic reticulum in an unfolded/misfolded state. Increasing the efficiency of tyrosinase folding using chemical chaperones led to a reduction in the level of substrate available to the proteasome and decreased the expression of a tyrosinase-derived epitope. Conversely, in transfectants expressing tyrosinase mutants that are completely misfolded, both proteasome substrate and epitope presentation were significantly enhanced. Proteasome substrate availability was a consequence of misfolding and not simply due to retention in the endoplasmic reticulum. Thus, the extent of folding/misfolding of a full-length protein is an important determinant of the level of epitope presentation.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15728460     DOI: 10.4049/jimmunol.174.5.2544

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  21 in total

Review 1.  DRiPs solidify: progress in understanding endogenous MHC class I antigen processing.

Authors:  Jonathan W Yewdell
Journal:  Trends Immunol       Date:  2011-09-29       Impact factor: 16.687

Review 2.  Cellular stress response and innate immune signaling: integrating pathways in host defense and inflammation.

Authors:  Sujatha Muralidharan; Pranoti Mandrekar
Journal:  J Leukoc Biol       Date:  2013-08-29       Impact factor: 4.962

3.  Hydrophobicity as a driver of MHC class I antigen processing.

Authors:  Lan Huang; Matthew C Kuhls; Laurence C Eisenlohr
Journal:  EMBO J       Date:  2011-03-04       Impact factor: 11.598

Review 4.  Unraveling the regulatory role of endoplasmic-reticulum-associated degradation in tumor immunity.

Authors:  Xiaodan Qin; William D Denton; Leah N Huiting; Kaylee S Smith; Hui Feng
Journal:  Crit Rev Biochem Mol Biol       Date:  2020-07-07       Impact factor: 8.250

5.  Prediction of cellular immune responses against CFTR in patients with cystic fibrosis after gene therapy.

Authors:  Joanita Figueredo; Maria P Limberis; James M Wilson
Journal:  Am J Respir Cell Mol Biol       Date:  2007-01-11       Impact factor: 6.914

Review 6.  Translating DRiPs: progress in understanding viral and cellular sources of MHC class I peptide ligands.

Authors:  Brian P Dolan; Jack R Bennink; Jonathan W Yewdell
Journal:  Cell Mol Life Sci       Date:  2011-03-17       Impact factor: 9.261

7.  The nature and extent of contributions by defective ribosome products to the HLA peptidome.

Authors:  Dmitry Bourdetsky; Christian E H Schmelzer; Arie Admon
Journal:  Proc Natl Acad Sci U S A       Date:  2014-04-08       Impact factor: 11.205

8.  Stressed Out - Therapeutic Implications of ER Stress Related Cancer Research.

Authors:  Randal Riha; Pooja Gupta-Saraf; Payel Bhanja; Samyak Badkul; Subhrajit Saha
Journal:  Oncomedicine       Date:  2017-09-27

Review 9.  Cellular stress and innate inflammation in organ-specific autoimmunity: lessons learned from vitiligo.

Authors:  John E Harris
Journal:  Immunol Rev       Date:  2016-01       Impact factor: 12.988

10.  Vesicular Stomatitis Virus Encoding a Destabilized Tumor Antigen Improves Activation of Anti-tumor T Cell Responses.

Authors:  Amanda L Huff; Laura Evgin; Jill Thompson; Tim Kottke; Christopher B Driscoll; Jason Tonne; Phonphimon Wongthida; Matthew Schuelke; Kevin G Shim; Georges Mer; Marina Ramirez-Alvarado; Richard Vile
Journal:  Mol Ther       Date:  2020-08-25       Impact factor: 11.454

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.